{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:13:02Z","timestamp":1792818782834,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG061083"],"award-info":[{"award-number":["AG061083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anosognosia, the lack of awareness of memory decline, and Neuropsychiatric Symptoms (NPS) are prevalent and debilitating symptoms in Alzheimer\u2019s disease (AD) dementia. Understanding the coexistence of these symptoms may help guide clinical interventions and treatment strategies. This study aimed to compare NPS prevalence in patients with and without anosognosia at baseline and to assess the association between anosognosia and NPS over time. We examined patients with AD dementia enrolled in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). To be included in the current study, patients had to have undergone baseline assessments and at least one subsequent follow-up evaluation. Furthermore, all patients had to have amyloid (as assessed using Positron Emission Tomography, PET), Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), and Everyday Cognition (ECog) variables available throughout the study. Anosognosia, our exposure of interest, was determined using Ecog scores from patients and study partners. Study partners evaluated the presence or absence of 12 NPS (our outcomes of interest) using the NPI. Cox proportional hazards models, excluding patients who had any symptoms of NPS at baseline, were used to evaluate NPS onset by group (anosognosia\/no anosognosia) while adjusting for age, sex, years of education, and MMSE. 112 patients with follow-up data (mean\u2009=\u20091 year) were included in this study. Of these, 47.3% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200953) had anosognosia, while 52.7% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200959) did not. In those with anosognosia at baseline, we observed a trend toward greater prevalence of agitation and motor symptoms. Exploratory time-to-event analysis demonstrated that the patients with anosognosia had a faster onset of apathy (HR: 2.78, 95% CI: 1.37\u20135.62,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01) compared to the patients without anosognosia. In this exploratory study, while there were no significant differences in frequency of NPS at baseline between the groups, patients with anosognosia demonstrated faster onset of apathy as compared to patients without anosognosia. These findings underscore the importance of longitudinal assessments and tailored interventions targeting the management of NPS in AD dementia patients with anosognosia. Further research is warranted to explain the underlying mechanisms driving these associations and to inform the development of targeted therapeutic strategies aimed at improving patient outcomes in this population.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-29569-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:54:41Z","timestamp":1764852881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between anosognosia and neuropsychiatric symptoms in Alzheimer\u2019s disease dementia patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Michael","family":"Elnemais Fawzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phebe","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gatchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"29569_CR1","unstructured":"Association, A. Alzheimer\u2019s Disease Facts and Figures. 2021. (2021)."},{"key":"29569_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cortex.2014.07.019","volume":"61","author":"SE Starkstein","year":"2014","unstructured":"Starkstein, S. E. Anosognosia in Alzheimer\u2019s disease: diagnosis, frequency, mechanism and clinical correlates. Cortex 61, 64\u201373 (2014).","journal-title":"Cortex"},{"issue":"2","key":"29569_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/01688639308402560","volume":"15","author":"BR Reed","year":"1993","unstructured":"Reed, B. R., Jagust, W. J. & Coulter, L. Anosognosia in Alzheimer\u2019s disease: relationships to depression, cognitive function, and cerebral perfusion. J. Clin. Exp. Neuropsychol. 15 (2), 231\u2013244 (1993).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"29569_CR4","unstructured":"Prigatano, G. P. The Study of Anosognosia (Pxford university, 2010)."},{"key":"29569_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00002093-199509020-00007","volume":"9","author":"KD McDaniel","year":"1995","unstructured":"McDaniel, K. D., Edland, S. D. & Heyman, A. Relationship between level of insight and severity in Alzheimer\u2019s disease. CERAD clinical investigators. Alzheimer\u2019s Dis. Assoc. Disorders. 9, 101\u2013104 (1995).","journal-title":"Alzheimer\u2019s Dis. Assoc. Disorders"},{"key":"29569_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1162\/jocn.1991.3.2.183","volume":"3","author":"SM McGlynn","year":"1991","unstructured":"McGlynn, S. M. & Kaszniak, A. W. When metacognition fails: impaired awareness of deficit in Alzheimer\u2019s disease. J. Cogn. Neurosci. 3, 181\u2013187 (1991).","journal-title":"J. Cogn. Neurosci."},{"issue":"2","key":"29569_CR7","first-page":"83","volume":"13","author":"DG Harwood","year":"2000","unstructured":"Harwood, D. G., Sultzer, D. L. & Wheatley, M. V. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol. Behav. Neurol. 13 (2), 83\u201388 (2000).","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"issue":"5","key":"29569_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/jnnp.61.5.485","volume":"61","author":"SE Starkstein","year":"1996","unstructured":"Starkstein, S. E., Sabe, L., Chemerinski, E., Jason, L. & Leiguarda, R. Two domains of anosognosia in Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatry. 61 (5), 485\u2013490 (1996).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"29569_CR9","doi-asserted-by":"crossref","unstructured":"Zanetti, O. et al. Insight in dementia: when does it occur? Evidence for a nonlinear relationship between insight and cognitive status. J. Gerontol. B Psychol. Sci. Soc. Sci. 54(2), P100-6 (1999).","DOI":"10.1093\/geronb\/54B.2.P100"},{"key":"29569_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1192\/bjp.171.1.47","volume":"171","author":"SE Starkstein","year":"1997","unstructured":"Starkstein, S. E. et al. Prospective longitudinal study of depression and anosognosia in Alzheimer\u2019s disease. Br. J. Psychiatry. 171, 47\u201352 (1997).","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"29569_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/089198879100400402","volume":"4","author":"CA Mangone","year":"1991","unstructured":"Mangone, C. A. et al. Impaired insight in Alzheimer\u2019s disease. J. Geriatr. Psychiatry Neurol. 4 (4), 189\u2013193 (1991).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"3","key":"29569_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1176\/jnp.7.3.338","volume":"7","author":"R Migliorelli","year":"1995","unstructured":"Migliorelli, R. et al. Anosognosia in Alzheimer\u2019s disease: a study of associated factors. J. Neuropsychiatry Clin. Neurosci. 7 (3), 338\u2013344 (1995).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1","key":"29569_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S1041610205002772","volume":"18","author":"P Aalten","year":"2006","unstructured":"Aalten, P. et al. Awareness and behavioral problems in dementia patients: a prospective study. Int. Psychogeriatr. 18 (1), 3\u201317 (2006).","journal-title":"Int. Psychogeriatr."},{"issue":"3","key":"29569_CR14","first-page":"176","volume":"8","author":"B Seltzer","year":"1995","unstructured":"Seltzer, B., Vasterling, J. J., Hale, M. A. & Khurana, R. Unawareness of memory deficit in Alzheimer\u2019s disease: relation to mood and other disease variables. Cogn. Behav. Neurol. 8 (3), 176\u2013181 (1995).","journal-title":"Cogn. Behav. Neurol."},{"issue":"3","key":"29569_CR15","first-page":"197","volume":"10","author":"JJ Vasterling","year":"1997","unstructured":"Vasterling, J. J., Seltzer, B. & Watrous, W. E. Longitudinal assessment of deficit unawareness in Alzheimer\u2019s disease. Neuropsychiatry Neuropsychol. Behav. Neurol. 10 (3), 197\u2013202 (1997).","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"29569_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/gps.3824","volume":"S I28","author":"O Turro-Garriga","year":"2013","unstructured":"Turro-Garriga, O., et al. Burden associated with the presence of anosognosia in Alzheimer\u2019s disease. Int. J. Geriatr. Psychatr. S I28, 291\u2013297 (2013).","journal-title":"Int. J. Geriatr. Psychatr"},{"key":"29569_CR17","unstructured":"Prigatano, G. P. Historical observation relevant to the study of anosognosia, in The study of anosognosia, G.P. Prigatano, Editor. Oxford university press: Oxford. (2010)."},{"issue":"10","key":"29569_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/ene.13076","volume":"23","author":"N Boublay","year":"2016","unstructured":"Boublay, N., Schott, A. M. & Krolak-Salmon, P. Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease: a review of 20 years of research. Eur. J. Neurol. 23 (10), 1500\u20131509 (2016).","journal-title":"Eur. J. Neurol."},{"key":"29569_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","volume":"190","author":"QF Zhao","year":"2016","unstructured":"Zhao, Q. F. et al. The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: systematic review and meta-analysis. J. Affect. Disord. 190, 264\u2013271 (2016).","journal-title":"J. Affect. Disord"},{"issue":"12","key":"29569_CR20","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","volume":"288","author":"CG Lyketsos","year":"2002","unstructured":"Lyketsos, C. G. et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Jama 288 (12), 1475\u20131483 (2002).","journal-title":"Jama"},{"key":"29569_CR21","doi-asserted-by":"crossref","unstructured":"Conde-Sala, J. L. et al. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer\u2019s disease: a 24-month follow-up study. Int. J. Geriatr. Psychiatry. 31(2), 109\u2013119 (2016).","DOI":"10.1002\/gps.4298"},{"issue":"5","key":"29569_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/13607860500143075","volume":"9","author":"P Aalten","year":"2005","unstructured":"Aalten, P., van Valen, E., Clare, L., Kenny, G. & Verhey, F. Awareness in dementia: a review of clinical correlates. Aging Ment Health. 9 (5), 414\u2013422 (2005).","journal-title":"Aging Ment Health"},{"key":"29569_CR23","doi-asserted-by":"crossref","unstructured":"Arkin, S. & Mahendra, N. Insight in Alzheimer\u2019s patients: results of a longitudinal study using three assessment methods. Am. J. Alzheimers Dis. Other Demen. 16(4), 211\u2013224 (2001).","DOI":"10.1177\/153331750101600401"},{"key":"29569_CR24","doi-asserted-by":"crossref","unstructured":"Robert, P. H. et al. The apathy inventory: assessment of apathy and awareness in Alzheimer\u2019s disease, Parkinson\u2019s disease and mild cognitive impairment. Int. J. Geriatr. Psychiatry. 17(12), 1099\u20131105 (2002).","DOI":"10.1002\/gps.755"},{"issue":"12","key":"29569_CR25","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/gps.4275","volume":"30","author":"E Mak","year":"2015","unstructured":"Mak, E., Chin, R., Ng, L. T., Yeo, D. & Hameed, S. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer\u2019s disease. Int. J. Geriatr. Psychiatry. 30 (12), 1207\u20131214 (2015).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"12","key":"29569_CR26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/(SICI)1099-1166(199912)14:12<1019::AID-GPS61>3.0.CO;2-F","volume":"14","author":"C Derouesn\u00e9","year":"1999","unstructured":"Derouesn\u00e9, C. et al. Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. Int. J. Geriatr. Psychiatry. 14 (12), 1019\u20131030 (1999).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"4","key":"29569_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1176\/jnp.2010.22.4.378","volume":"22","author":"SE Starkstein","year":"2010","unstructured":"Starkstein, S. E., Brockman, S., Bruce, D. & Petracca, G. Anosognosia is a significant predictor of apathy in Alzheimer\u2019s disease. J. Neuropsychiatry Clin. Neurosci. 22 (4), 378\u2013383 (2010).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"6","key":"29569_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1468-1331.1995.tb00171.x","volume":"2","author":"SE Starkstein","year":"1995","unstructured":"Starkstein, S. E. et al. The prevalence and clinical correlates of apathy and irritability in Alzheimer\u2019s disease. Eur. J. Neurol. 2 (6), 540\u2013546 (1995).","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"29569_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/01688639008400980","volume":"12","author":"BH DeBettignies","year":"1990","unstructured":"DeBettignies, B. H., Mahurin, R. K. & Pirozzolo, F. J. Insight for impairment in independent living skills in Alzheimer\u2019s disease and multi-infarct dementia. J. Clin. Exp. Neuropsychol. 12 (2), 355\u2013363 (1990).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"29569_CR30","doi-asserted-by":"crossref","unstructured":"Landau, S. M. et al. Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J. Nucl. Med., 56(4), 567\u2013574 (2015).","DOI":"10.2967\/jnumed.114.148981"},{"issue":"5","key":"29569_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ana.410070516","volume":"7","author":"WG Rosen","year":"1980","unstructured":"Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R. & Peck, A. Pathological verification of ischemic score in differentiation of dementias. Ann. Neurol. 7 (5), 486\u2013488 (1980).","journal-title":"Ann. Neurol."},{"key":"29569_CR32","doi-asserted-by":"crossref","unstructured":"Farias, S. T. et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology, 22(4), 531\u2013544 (2008).","DOI":"10.1037\/0894-4105.22.4.531"},{"key":"29569_CR33","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Anosognosia is Associated with Increased Prevalence and Faster Development of Neuropsychiatric Symptoms in Mild Cognitive Impairment. Frontiers in Aging Neuroscience, Mar 6;16:1335878.(2024).","DOI":"10.3389\/fnagi.2024.1335878"},{"key":"29569_CR34","doi-asserted-by":"crossref","unstructured":"Cummings, J. L. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 48(5 Suppl 6), S10\u2013S16 (1997).","DOI":"10.1212\/WNL.48.5_Suppl_6.10S"},{"issue":"3","key":"29569_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.72","volume":"49","author":"S Tekin","year":"2001","unstructured":"Tekin, S. et al. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in alzheimer disease. Ann. Neurol. 49 (3), 355\u2013361 (2001).","journal-title":"Ann. Neurol."},{"key":"29569_CR36","doi-asserted-by":"crossref","unstructured":"Trzepacz, P. T. et al. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 9(5 Suppl), S95\u2013S104.e1. (2013).","DOI":"10.1016\/j.jalz.2012.10.005"},{"issue":"1","key":"29569_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1447-0594.2008.00512.x","volume":"9","author":"T Akai","year":"2009","unstructured":"Akai, T., Hanyu, H., Sakurai, H., Sato, T. & Iwamoto, T. Longitudinal patterns of unawareness of memory deficits in mild Alzheimer\u2019s disease. Geriatr. Gerontol. Int. 9 (1), 16\u201320 (2009).","journal-title":"Geriatr. Gerontol. Int."},{"issue":"2","key":"29569_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/WAD.0b013e31822c55c4","volume":"26","author":"L Clare","year":"2012","unstructured":"Clare, L. et al. Longitudinal trajectories of awareness in early-stage dementia. Alzheimer Dis. Assoc. Disord. 26 (2), 140\u2013147 (2012).","journal-title":"Alzheimer Dis. Assoc. Disord"},{"key":"29569_CR39","doi-asserted-by":"crossref","unstructured":"Vannini, P. et al. Trajectory of unawareness of memory decline in individuals with autosomal dominant alzheimer disease. JAMA Netw. Open., 3(12), e2027472 (2020).","DOI":"10.1001\/jamanetworkopen.2020.27472"},{"key":"29569_CR40","first-page":"1","volume":"00","author":"BJ Hanseeuw","year":"2020","unstructured":"Hanseeuw, B. J. et al. Evolution of anosognosia in Alzheimer\u2019s disease and its relationship to amyloid. Annals Neurol.\u00a087(2):267-280\u00a0(2020).","journal-title":"Annals Neurol."},{"key":"29569_CR41","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1212\/WNL.0000000000001935","volume":"85","author":"RS Wilson","year":"2015","unstructured":"Wilson, R. S. et al. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology, 85: 984\u2013991 (2015).","journal-title":"Neurology"},{"issue":"2","key":"29569_CR42","first-page":"753","volume":"59","author":"F Cacciamani","year":"2017","unstructured":"Cacciamani, F. et al. Low cognitive awareness, but not complaint, is a good marker of preclinical Alzheimer\u2019s disease. J. Alzheimers Dis. 59 (2), 753\u2013762 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"29569_CR43","doi-asserted-by":"crossref","unstructured":"Weiner, M. W. et al. Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer\u2019s Disease Neuroimaging Initiative 4. Alzheimers Dement. 19(1), 307\u2013317 (2023).","DOI":"10.1002\/alz.12797"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29569-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29569-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:06:36Z","timestamp":1767621996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29569-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29569"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29569-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}